标题
Pathogenesis-targeted therapeutic strategies in Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 34, Issue 1, Pages 41-44
出版商
Wiley
发表日期
2018-11-29
DOI
10.1002/mds.27534
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- Is Parkinson’s disease a lysosomal disorder?
- (2018) Andrés D Klein et al. BRAIN
- Immunologic treatment of Parkinson's disease
- (2018) Joseph Jankovic Immunotherapy
- Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease
- (2018) Rizwan S. Akhtar et al. JOURNAL OF NEUROCHEMISTRY
- Autoimmune and paraneoplastic movement disorders: An update
- (2018) José Fidel Baizabal-Carvallo et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
- (2018) S. Pablo Sardi et al. MOVEMENT DISORDERS
- Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
- (2018) Anthony E. Lang et al. MOVEMENT DISORDERS
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
- (2018) Joseph Jankovic et al. JAMA Neurology
- Selective autophagy as a potential therapeutic target for neurodegenerative disorders
- (2018) Aurora Scrivo et al. LANCET NEUROLOGY
- Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
- (2018) Changyoun Kim et al. Molecular Neurodegeneration
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- Parkinson's Disease Is Not Simply a Prion Disorder
- (2017) D. James Surmeier et al. JOURNAL OF NEUROSCIENCE
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
- (2017) Ying-Chou Chen et al. MOLECULAR CELL
- Media hype: Patient and scientific perspectives on misleading medical news
- (2017) Israel Robledo et al. MOVEMENT DISORDERS
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States
- (2017) Karl Kieburtz et al. MOVEMENT DISORDERS
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
- (2017) Yvette C Wong et al. NATURE MEDICINE
- Parkinson disease: Exenatide – a drug for diabetes and Parkinson disease?
- (2017) Joseph Jankovic Nature Reviews Neurology
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- Diagnosis and Management of Parkinson's Disease
- (2017) Joseph Jankovic et al. SEMINARS IN NEUROLOGY
- Exploring Braak’s Hypothesis of Parkinson’s Disease
- (2017) Carmen D. Rietdijk et al. Frontiers in Neurology
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
- (2017) Antonio Martin-Bastida et al. Scientific Reports
- Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
- (2016) Qi Qin et al. CNS Neuroscience & Therapeutics
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
- (2015) Markus Mandler et al. Molecular Neurodegeneration
- α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
- (2015) W. Peelaerts et al. NATURE
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- Parkinson Disease Subtypes
- (2014) Mary Ann Thenganatt et al. JAMA Neurology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started